Head of Clinical Development
- Newly created senior opportunity
- Collaborative, driven and dedicated team
- Located in the Parkville Precinct at Bio21 Institute
The Head of Clinical Development is a newly created position, reporting directly to the CEO of Aculeus Therapeutics. Working closely with the Head of Medicinal Chemistry and Head of Immuno-biology, the Head of Clinical Development will play a vital role in shaping the future growth and direction, including operational aspects, of trial related activities of the small molecule portfolio.
The Head of Clinical Development will provide strategic and operational expertise to the organisation to support the building of internal early clinical trials capability, including first-in-human studies. The incumbent will establish the clinical project plan, coordinate partner agreements for multi-site Phase I and II Oncology trials and create a project specific governance framework that complies with relevant legislation. Working with key research partners, consultants and hospital stakeholders, the Head of Clinical Development will oversee the establishment and maintenance of trial sites in accordance with protocols and relevant regulatory guidelines across various jurisdictions.
The successful candidate will have completed a PhD/Masters Degree in pharmacology, immunology, drug development or related and have gained experience within a research, biotechnology and/or pharmaceutical environment, with early stage clinical oncology trials. A well-developed understanding of small molecule drug discovery and development, particularly in oncology will be key to the success of this role, as will the ability to build strong relationships with a wide range of external stakeholders.
The incumbent will be commercially astute, outcomes focused with the ability to be resourceful and tenacious in approach.
This is an exciting time to join a growing start up biotechnology company that is on a strong growth trajectory and an opportunity to contribute to the future strategic direction of the organisation.
Aculeus Therapeutics is a biotech company developing small molecule therapeutics in the immuno-oncology and anti-viral space. Aculeus is a semi-virtual operation overseen by an experienced board of directors and led by a small team of experienced drug discovery and development scientists. With a major footprint in the immunity/immune-oncology landscape in Australia, Aculeus is supported by committed leading Australian and International research partners and contract research organisations to rapidly progress therapeutic programs.
To apply – please click on ‘APPLY NOW’ and using reference ATHhcd0423 address your cover letter and resume to Sandra Kerr of Fisher Leadership, or call 1300 347 437 for further information.